Anbio Biotechnology (NNNN)

Anbio Biotechnology (NNNN) is a biotechnology company whose Class A ordinary shares are listed on the Nasdaq. Based on its public positioning, the company is focused on in vitro diagnostics, developing and selling test products used to detect diseases and health conditions from biological samples.

Diagnostic businesses of this kind typically supply rapid tests and laboratory assays to healthcare providers, distributors and other customers in multiple international markets. Further details about the company's specific product lines, regulatory approvals and operating locations should be confirmed in its official filings.